The United States and Russia have drafted a plan to end the war in Ukraine. The proposal would force Ukraine to surrender territory, reduce its military, and accept strict limits …
The U.S. Food and Drug Administration (FDA) has approved a new drug, Kisunla (donanemab), aimed at treating Alzheimer’s disease. This approval is a significant development for patients in the early …